Froedtert has enrolled its first patient in a new breakthrough trial of an antiviral drug to fight the coronavirus.
Remdesivir has been praised by top health officials as a way to treat COVID-19 patients, including from Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci.
"What it has proven is that a drug can block this virus," Dr. Fauci said in late April. "The data shows that Remdesivir has a clear-cut significant positive effect in diminishing the time to recovery."
- Coronavirus in Wisconsin: Live Updates From Across the State
- The Rebound Milwaukee: Resources For Getting Back To Normal
- We're Open: These Restaurants Are Still Offering Carryout And Delivery
Froedtert Hospital in Wauwatosa is a part of a program with Gilead Sciences, the drug's manufacturer.
On Thursday, a hospital spokesperson said it has enrolled its first patient into the program.
The hospital will only be able to provide the drug to 10 patients who are on ventilators and have a certain level of kidney and liver function.